How do I subscribe to ongoing alerts?

Subscribe to /feed/company/merck-healthcare-kgaa-darmstadt-germany-an-affiliate-of-merck-kgaa-darmstadt-ger.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany pipeline: 1 marketed, 0 filed, 4 Phase 3, 5 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 4 Phase 3 5 Phase 2 32 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Mavenclad®	Mavenclad®	marketed	Purine nucleoside analog; immunosuppressant	Deoxyadenosine kinase; DNA synthesis and repair pathways in lymphocytes	Immunology; Neurology
Coriogonadotropin alfa	Coriogonadotropin alfa	phase 3	Gonadotropin; hCG analog	Luteinizing hormone/chorionic gonadotropin receptor (LHCGR)	Reproductive Medicine / Fertility
Cladribine High Dose	Cladribine High Dose	phase 3	Purine nucleoside analog	DNA (via deoxyadenosine analog incorporation)	Oncology, Immunology
Cladribine Low Dose	Cladribine Low Dose	phase 3	Purine nucleoside analog	Ribonucleotide reductase; DNA synthesis	Immunology
Palcebo	Palcebo	phase 3			Other

Therapeutic area mix

Other · 2
Diabetes · 1
Immunology · 1
Immunology; Neurology · 1
Oncology, Immunology · 1
Reproductive Medicine / Fertility · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ADvantage Therapeutics · 1 shared drug class
AJU Pharm Co., Ltd. · 1 shared drug class
AO GENERIUM · 1 shared drug class
Abbott · 1 shared drug class
AceLink Therapeutics, Inc. · 1 shared drug class
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
Aciex Therapeutics, Inc. · 1 shared drug class
3D Medicines (Beijing) Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany:

Cite this brief

Drug Landscape (2026). Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/merck-healthcare-kgaa-darmstadt-germany-an-affiliate-of-merck-kgaa-darmstadt-ger. Accessed 2026-05-17.